AQR Capital Management - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 194 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$365,000
-55.9%
58,993
-28.9%
0.00%0.0%
Q2 2019$828,000
-73.3%
82,919
-65.5%
0.00%
-66.7%
Q1 2019$3,100,000
+4.1%
240,669
+22.8%
0.00%0.0%
Q4 2018$2,977,000
+117.9%
195,995
+90.1%
0.00%
+200.0%
Q4 2017$1,366,000
-68.3%
103,114
-55.8%
0.00%
-80.0%
Q3 2017$4,305,000
-25.4%
233,319
-25.6%
0.01%
-37.5%
Q2 2017$5,767,000
+39.6%
313,424
+71.0%
0.01%
+60.0%
Q1 2017$4,132,000
+77.7%
183,260
+174.3%
0.01%
+66.7%
Q4 2016$2,325,000
+30.0%
66,799
-8.4%
0.00%0.0%
Q3 2016$1,788,000
+31.8%
72,937
+28.6%
0.00%
+50.0%
Q2 2016$1,357,000
-5.8%
56,721
-7.8%
0.00%
-33.3%
Q1 2016$1,440,000
-4.3%
61,533
+23.5%
0.00%0.0%
Q4 2015$1,504,000
-54.5%
49,827
-40.1%
0.00%
-57.1%
Q3 2015$3,304,000
+1.5%
83,178
+76.6%
0.01%
+16.7%
Q2 2015$3,254,000
+117.8%
47,107
+72.3%
0.01%
+100.0%
Q1 2015$1,494,000
+254.0%
27,340
+176.2%
0.00%
+200.0%
Q4 2014$422,000
-64.2%
9,900
-83.8%
0.00%
-75.0%
Q1 2014$1,180,000
-22.2%
61,000
-2.4%
0.00%
-20.0%
Q4 2013$1,517,000
+11.4%
62,500
-1.4%
0.01%0.0%
Q3 2013$1,362,000
-29.5%
63,400
-27.0%
0.01%
-28.6%
Q2 2013$1,932,000
+215.2%
86,827
+108.2%
0.01%
+133.3%
Q4 2012$613,00041,7000.00%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
HealthInvest Partners AB 520,000$15,699,0007.39%
Palo Alto Investors LP 2,835,792$85,613,0004.76%
Opaleye Management Inc. 150,000$4,529,0001.89%
Engaged Capital LLC 61,425$1,854,0001.15%
IRONWOOD INVESTMENT MANAGEMENT LLC 91,400$2,759,0001.14%
Endurant Capital Management LP 111,180$3,357,0001.12%
AlphaOne Investment Services, LLC 86,817$2,621,0000.94%
ASHFORD CAPITAL MANAGEMENT INC 127,625$3,853,0000.91%
ARDSLEY ADVISORY PARTNERS LP 205,000$6,189,0000.81%
STELLIAM INVESTMENT MANAGEMENT, LP 685,000$20,680,0000.62%
View complete list of AMAG PHARMACEUTICALS INC shareholders